Erie County Medical Center is a medicare approved dialysis facility center in Buffalo, New York and it has 36 dialysis stations. It is located in Erie county at 462 Grider Street, Buffalo, NY, 14215. You can reach out to the office of Erie County Medical Center at (716) 898-1400. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Erie County Medical Center has the following ownership type - Non-Profit. It was first certified by medicare in January, 1980. The medicare id for this facility is 330219 and it accepts patients under medicare ESRD program.
| Name | Erie County Medical Center |
|---|---|
| Location | 462 Grider Street, Buffalo, New York |
| No. of Dialysis Stations | 36 |
| Medicare ID | 330219 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | Yes |
| 462 Grider Street, Buffalo, New York, 14215 | |
| (716) 898-1400 | |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
| NPI Number | 1437197985 |
| Doing Business As | Erie County Medical Center Corporation |
| Address | 462 Grider St Buffalo, New York, 14215 |
| Phone Number | (716) 898-5931 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 98 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 5 |
| Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 1 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 165 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1566 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
| Adult patients getting regular peritoneal dialysis at the center | 12 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 65 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 69 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Erie County Medical Center with elevated calcium levels.
| Patients with hypercalcemia | 197 |
| Hypercalcemia patient months | 1889 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 200 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 24 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 29 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 132 |
| Patient months included in arterial venous fistula and catheter summaries | 1034 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 16 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 157 |
| Hospitalization Rate in facility | 184 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 273.7 |
| Hospitalization Rate: Lower Confidence Limit | 131.3 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Erie County Medical Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.8 |
| Readmission Rate: Lower Confidence Limit | 19.7 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Erie County Medical Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.73 (Worse than Expected) |
| SIR: Upper Confidence Limit | 2.6 |
| SIR: Lower Confidence Limit | 1.1 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Erie County Medical Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 139 |
| Transfusion Rate in facility | 46.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 79.2 |
| Transfusion Rate: Lower Confidence Limit | 28.8 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Erie County Medical Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 843 |
| Mortality Rate in facility | 19.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.2 |
| Mortality Rate: Lower Confidence Limit | 16.1 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago
Erie County Medical Center Location: 462 Grider Street, Buffalo, New York, 14215 Phone: (716) 898-1400 |
Cleve Hill Dialysis Center Location: 1461 Kensington Avenue, Buffalo, New York, 14215 Phone: (716) 831-8892 |
Us Renal Care West Cheektowaga Location: 2861 Harlem Road, Buffalo, New York, 14225 Phone: (716) 891-7429 |
News Archive
The U.S. Army Chemical Materials Agency (CMA) marked the destruction of all VX nerve agent munitions at its destruction sites on Wednesday, Dec. 24, 2008.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.
ProUroCare Medical Inc. announced today that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified.
Offering methadone treatment to people who use injection drugs "substantially reduces the risk that they will get HIV or give it to anyone else," according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports.
In the current issue of Psychotherapy and Psychosomatics, a group of French investigators headed by Guy Chouinard presents data that indicate that grief after the loss of a significant other may become a disease. One issue facing the DSM-V in the revision of the criteria for major depressive disorder (MDD) concerns bereavement criterion E, which often leads to exclusion from major depressive episode (MDE).
› Verified 1 days ago